Evidence map›Paper›PMID 23387911›Full record

ArticleThe journal of sexual medicine2013

Development of the NIH PROMIS ® Sexual Function and Satisfaction measures in patients with cancer.

Kathryn E Flynn, Li Lin, Jill M Cyranowski, Bryce B Reeve, Jennifer Barsky Reese, Diana D Jeffery, Ashley Wilder Smith, Laura S Porter, Carrie B Dombeck, Deborah Watkins Bruner and 2 more

4 registry-linked trialsAbstract readValidation Study
In one paragraph

Article in The journal of sexual medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 93 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02290223 nacompletednot on this mapstarted 2015, after this paper: background citation

Patient Activation to Address Chronic Pain and Opioid Management in Primary Care

TypeinterventionalSponsorKaiser PermanenteRan2015 to 2017Enrolled376ConditionsChronic PainArmsBehavioral Based Treatment Model
NCT05349227 narecruitingnot on this mapstarted 2022, after this paper: background citation

Comprehensive Outcomes for After Cancer Health (COACH): the Feasibility and Impact of an MHealth Augmented Coaching Program for Self-Management in Cancer Survivors

TypeinterventionalSponsorPack HealthRan2022 to 2027Enrolled625ConditionsOvarian Cancer, Breast Cancer, Lung Cancer, Gastric CancerArmsDigital Health Coaching Program, Fitbit
NCT05437939 active not recruitingnot on this mapstarted 2022, after this paper: background citation

Identifying Opportunities for Prevention of Adverse Outcomes Following Female Genital

TypeobservationalSponsorUniversity of California, San FranciscoRan2022 to 2026Enrolled802ConditionsFemale Genital Fistula, Incontinence
NCT06121258 nacompletednot on this mapstarted 2024, after this paper: background citation

Sexual Health and Breast Cancer: Developing Appropriate Education for Women Going Through Treatment

TypeinterventionalSponsorUniversity of Colorado, DenverRan2024 to 2025Enrolled32ConditionsBreast Cancer Female, Sexual DysfunctionArmsEducational video series
3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Sexual problems in patients with hematological diseases: a systematic literature review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kathryn E FlynnDepartment of Psychiatry and Behavioral Sciences, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27705, USA. kathryn.flynn@duke.edu
Li Lin
Jill M Cyranowski
Bryce B Reeve
Jennifer Barsky Reese
Diana D Jeffery
Ashley Wilder Smith
Laura S Porter
Carrie B Dombeck
Deborah Watkins Bruner
Francis J Keefe
Kevin P Weinfurt

Funding

Validating and Extending the PROMIS Sexual Function Measure for Clinical ResearchU01AR052186 · NIAMS · DUKE UNIVERSITY · PI WEINFURT, KEVIN P · 2004 to 2013
$9.5M
NIAMS NIH HHS U01 AR052186NIAMS NIH HHS U01AR052186
6 · The paper itself

Abstract

introductionWe describe the development and validation of the Patient-Reported Outcomes Measurement Information System(®) Sexual Function and Satisfaction (PROMIS(®) SexFS; National Institutes of Health) measures, version 1.0, for cancer populations.

aimTo develop a customizable self-report measure of sexual function and satisfaction as part of the U.S. National Institutes of Health PROMIS Network.

methodsOur multidisciplinary working group followed a comprehensive protocol for developing psychometrically robust patient-reported outcome measures including qualitative (scale development) and quantitative (psychometric evaluation) development. We performed an extensive literature review, conducted 16 focus groups with cancer patients and multiple discussions with clinicians, and evaluated candidate items in cognitive testing with patients. We administered items to 819 cancer patients. Items were calibrated using item-response theory and evaluated for reliability and validity.

main outcome measuresThe PROMIS SexFS measures, version 1.0, include 81 items in 11 domains: Interest in Sexual Activity, Lubrication, Vaginal Discomfort, Erectile Function, Global Satisfaction with Sex Life, Orgasm, Anal Discomfort, Therapeutic Aids, Sexual Activities, Interfering Factors, and Screener Questions.

resultsIn addition to content validity (patients indicate that items cover important aspects of their experiences) and face validity (patients indicate that items measure sexual function and satisfaction), the measure shows evidence for discriminant validity (domains discriminate between groups expected to be different) and convergent validity (strong correlations between scores on PROMIS and scores on conceptually similar older measures of sexual function), as well as favorable test-retest reliability among people not expected to change (interclass correlations from two administrations of the instrument, 1 month apart).

conclusionsThe PROMIS SexFS offers researchers a reliable and valid set of tools to measure self-reported sexual function and satisfaction among diverse men and women. The measures are customizable; researchers can select the relevant domains and items comprising those domains for their study.

Indexed as

Quality of LifeSelf ReportSexualityAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasmsPsychometricsReproducibility of ResultsSexual Dysfunction, PhysiologicalUnited States

Identifiers

PMID23387911
PMCPMC3729213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.